News5 months ago
This animal health stock is up 70% in 2025. JPMorgan says it has further gains
Elanco Animal Health is worth buying opportunity even after its rally this year, according to JPMorgan. Analyst Chris Schott on Tuesday upgraded Elanco to overweight from...
